13 Compañías | 22 productos médicos
The Epithod 616 COVID-19 IgM/IgG Test Kit is intended for the semi-quantitative detection of IgM and IgG antibodies to SARS-CoV-2 in whole blood, serum, and plasma from humans with a fast test time of less than two minutes. The gold nanoparticle-based immunoassay test kit is designed for use on the Epithod 616 analyzer which ensures better accuracy and improved sensitivity in analyzing results, and eliminates the risk of undesirable misreading.
YHLO’s IgG and IgM combined detection is a good supplementary diagnostic tool to PCR, which can identify who are immune to COVID-19 after infection in mass population and its titer change can be used to monitor treatment of COVID-19 patients. Together with iFlash fully automation system, manual work and aerosol contamination risk can be reduced. The assays are CE marked, FDA EUA application accepted and legal export qualification obtained.
The Novel Coronavirus (2019-nCoV) IgM/IgG Antibodies Detection Kit (Latex Chromatography) is intended for the qualitative detection of Coronavirus SARS-CoV-2 to enable preliminary screening of early infected patients. The easy-to-use test uses serum, plasma, whole blood and fingertip blood samples to deliver results that can be read with the naked eye in 15 minutes.